Mosedipimod Recruiting Phase 2 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04500132To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia